Category: For Physicians
For Physicians
Biomedical basis of the Barker hypothesis uncovered
According to the Barker hypothesis (also referred to as ‘small baby syndrome’), infants with too.
Deucravacitinib shows superiority to placebo, apremilast in treating psoriasis
Deucravacitinib improved psoriasis compared with placebo and apremilast in a phase 3 study, Bristol Myers.
Atopic dermatitis improvements with lebrikizumab similar across different races
Lebrikizumab had “generally consistent” results in improving atopic dermatitis across different races, according to results.
Microencapsulated formulation of benzoyl peroxide improves rosacea
Patients experienced a progressive improvement in rosacea after treatment with a benzoyl peroxide formulation, according.
Eating Disorders Are on the Rise
COVID-19 pandemic presents unique challenges to individuals with eating disorders Approximately 24 million people in.
Eggs and cholesterol back in the spotlight in new JAMA study
Not again, you may be thinking if you’ve come across the study by Zhong and.
New “guidelines” say continue red meat consumption habits, but recommendations contradict evidence
A controversial “dietary guidelines recommendation” published in Annals of Internal Medicine suggests that adults can.
Benefits of Long-Term Pulmonary Rehabilitation in Patients with Severe COPD.
In chronic obstructive pulmonary disease (COPD), the benefits of pulmonary rehabilitation (PR), which are: an.
Calprotectin May Be Biomarker of IPF Severity
Calprotectin may serve as a blood biomarker for disease severity in patients with idiopathic pulmonary.
Esbriet Plus Anti-PD-L1 Slows Lung Cancer and Fibrosis in Mouse Study
In mouse models of lung cancer and fibrosis, a combination of Esbriet (pirfenidone) and anti-PD-L1.